RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA
Clinical trials for RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for tough head and neck cancers
Disease control CompletedThis study tested a new treatment for people with advanced or recurrent head and neck cancer that cannot be cured with standard treatments. It combined a short, intense course of radiation (quad-shot) with immunotherapy drugs that help the immune system fight cancer. The goal was…
Matched conditions: RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated May 17, 2026 02:24 UTC
-
Immune cell combo shows promise in Tough-to-Treat head and neck cancers
Disease control CompletedThis early-phase study tested a new treatment for people with advanced head and neck cancer that has come back or spread. The treatment combines specially grown immune cells (memory-like NK cells) with drugs that help the immune system attack cancer. The main goal was to check sa…
Matched conditions: RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 14, 2026 12:01 UTC